The clinical content of preconception care: alcohol, tobacco, and illicit drug exposures

American Journal of Obstetrics and Gynecology

Volumn 199, Issue 6 SUPPL. B, 2008, Pages

  Floyd, R Louise ^a   Jack, Brian W ^b   Cefalo, Robert ^c   Atrash, Hani ^a   Mahoney, Jeanne ^d   Herron, Anne ^e   Husten, Corinne ^f   Sokol, Robert J ^g  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b BOSTON MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS   (United States)

^e SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION   (United States)

^f Partnership for Prevention   (United States)

^g WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

alcohol; preconception; substance abuse; women

Indexed keywords

ALCOHOL; BUPRENORPHINE; ILLICIT DRUG; METHADONE; NALTREXAMINE;

ALCOHOLISM; BLADDER CANCER; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; COCAINE DEPENDENCE; COGNITIVE THERAPY; DEPRESSION; DOMESTIC VIOLENCE; DRUG ABUSE; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG EXPOSURE; FETAL ALCOHOL SYNDROME; HEALTH BEHAVIOR; HEALTH HAZARD; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY CANCER; LUNG CANCER; LUNG DISEASE; MATERNAL CARE; PANCREAS CANCER; PREGNANCY; PREGNANCY OUTCOME; PRENATAL PERIOD; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCREENING; SEXUALLY TRANSMITTED DISEASE; SMOKING; SUBSTANCE ABUSE; TOBACCO; UNITED STATES;

ALCOHOL DRINKING; COST OF ILLNESS; FEMALE; HUMANS; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS; SMOKING; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 57149116135     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.09.018     Document Type: Review

References (71)

1. McGinnis J.M., and Foege W.H. Actual causes of death in the United States. JAMA 270 (1993) 2207-2212
2. Mokdad A.H., Marks J.S., Stroup D.F., and Gerberding J.L. Actual causes of death in the United States. [erratum appears in JAMA 2005;293:293-4]. JAMA 291 (2004) 1238-1245
3. Thacker S.B., Ikeda R.M., Gieseker K.E., et al. The evidence base for public health: informing policy at the Centers for Disease Control and Prevention. Am J Prev Med 28 (2005) 227.e1-227.e27
4. US Department of Health and Human Services. Healthy people 2010. With understanding and improving health. 2nd ed. Vol 1 (2000), US Government Printing Office, Washington, DC November
5. The health consequences of smoking: a report of the Surgeon General. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
6. Kramer M.S. Determinants of low birth weight: methodological assessment and meta-analysis. Bull World Health Organ 65 (1987) 663-737
7. DiFranza J.R., and Lew R.A. Effect of maternal cigarette smoking on pregnancy complications and sudden infant death syndrome. J Fam Pract 40 (1995) 385-394
8. Honein M.A., Rasmussen S.A., Reffhuis J., et al. Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology 18 (2007) 226-233
9. Ruiz P., Strain E.C., and Langrod J.G. The substance abuse handbook (2007), Lippincott Williams & Wilkins, Philadelphia, PA
10. Jack BW, Atrash H, Coonrod DV, Moos MK, Cefalo R, Johnson K. The clinical content of preconception care: an overview. Am J Obstet Gynecol.
11. Substance Abuse and Mental Health Services Administration. Results from the 2006 national survey on drug use and health: national findings. NSDUH series H-32, Department of Health and Human Services publication No. SMA 07-4923 (2007), Office of Applied Studies, Rockville, MD
12. Centers of Disease Control and Prevention. Alcohol consumption among women who are pregnant or who might become pregnant-United States, 2002. MMWR Morb Mortal Wkly Rep 53 (2004) 1178-1181
13. Streissguth A.P., and O'Malley K. Neuropsychiatric implications and long-term consequences of fetal alcohol spectrum disorders. Semin Clin Neuropsychiatry 5 (2000) 177-190
14. Kesmodel U., Wisbong K., Olsen S.F., Henriksen T.B., and Secher N.J. Moderate alcohol intake in pregnancy and the risk of spontaneous abortion. Alcohol Alcohol 37 (2002) 87-92
15. Windham G.C., Von Behren J., Fenster L., Schaefer C., and Swan S.H. Moderate maternal alcohol consumption and the risk of spontaneous abortion. Epidemiology 8 (1997) 509-514
16. Sokol R.J., Delaney-Black V., and Nordstrom B. Fetal alcohol spectrum disorder. JAMA 290 (2003) 2996-2999
17. In: Stratton K., Howe C., and Battaglia F. (Eds). Fetal alcohol syndrome: diagnosis, epidemiology, prevention and treatment (1996), Institute of Medicine National Academy Press, Washington, DC
18. Centers of Disease Control and Prevention. Guidelines for identifying and referring persons with fetal alcohol syndrome. MMWR Morb Mortal Wkly Rep 54 (2005) 1-15
19. Mattson S.N., and Schoenfeld R.E.P. Teratogenic effects of alcohol on brain and behavior. Alcohol Clin Exp Res 25 (2001) 185-191
20. American Academy of Pediatrics; Committee on Substance Abuse and Committee on Children with Disabilities. Fetal alcohol syndrome and alcohol-related neurodevelopmental disorders. Pediatrics 106 (2000) 358-361
21. Hanson J.W., Streissguth A.P., and Smith D.W. The effects of moderate alcohol consumption during pregnancy on fetal growth and morphogenesis. J Pediatr 92 (1978) 457-460
22. Maier S.E., and West J.R. Drinking patterns and alcohol-related birth defects. Alcohol Res Health 25 (2001) 168-174
23. Centers of Disease Control and Prevention. Fetal alcohol syndrome-Alaska, Arizona, Colorado, and New York, 1995-1977. MMWR Morb Mortal Wkly Rep 51 (2002) 433-435
24. May P.A., and Gossage J.P. Estimating the prevalence of fetal alcohol syndrome: a summary. Alcohol Res Health 25 (2001) 159-167
25. Lupton C., Burd L., and Harwood R. Cost of fetal alcohol spectrum disorders. Am J Med Genet 127C (2004) 3-9
26. Chang G. Alcohol-screening instruments for pregnant women. Alcohol Res Health 25 (2001) 204-209
27. Floyd R.L., O'Connor M.J., Bertrand J., and Sokol R. Reducing adverse outcomes from prenatal alcohol exposure: a clinical plan of action. Alcohol Clin Exp Res 30 (2006) 1271-1275
28. Bradley K.A., DeBenedetti A.F., Volk R.J., Williams E.C., Frank D., and Kivlahan D.R. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res 31 (2007) 1208-1217
29. Whitlock E.P., Polen M.R., Green C.A., Orleans T., and Klein J. Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 140 (2004) 557-568
30. US Preventive Services Task Force. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: recommendation statement. Ann Intern Med 140 (2004) 554-556
31. Bertholet N., Daeppen J.B., Wietlisback B.A., Fleming M., and Burnand B. Reduction of alcohol consumption by brief alcohol intervention in primary care: a systematic review and meta-analysis. Arch Intern Med 165 (2005) 986-995
32. Floyd R.L., Sobell M., Velasquez M.M., et al. Preventing alcohol-exposed pregnancies: a randomized controlled trial. Am J Prev Med 32 (2007) 1-10
33. Manwell L.B., Fleming M.F., Mundt M.P., Stauffacher E.A., and Barry K.L. Treatment of problem alcohol use in women of childbearing age: results of a brief intervention trial. Alcohol Clin Exp Res 24 (2000) 1517-1524
34. US Department of Health and Human Services. Helping patients who drink too much: a clinician's guide. National Institutes of Health. National Institute on Alcohol Abuse and Alcoholism. NIH Publication No. 07-3769. Rockville, MD. 2005.
35. American Academy of Pediatrics and the American College of Obstetricians and Gynecologists. Guidelines for perinatal care. 5th ed. (2002), American Academy of Pediatrics, Elk Grove Village, IL
36. Centers of Disease Control and Prevention. Smoking during pregnancy-United States, 1990-2002. MMWR Morb Mortal Wkly Rep 53 (2004) 911-915
37. Colman G.J., and Joyce T. Trends in smoking before, during, and after pregnancy in ten states. Am J Prev Med 24 (2003) 29-35
38. US Department of Health and Human Services. Health consequences of tobacco use among women. Women and smoking: a report of the surgeon general (177-450) (2001), US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, Rockville, MD
39. Salihu H.M., Aliyu M.H., Pierre-Louis B.J., and Alexander G.R. Levels of excess infant deaths attributable to maternal smoking during pregnancy in the United States. Matern Child Health J 7 (2003) 219-227
40. Ventura S.J., Hamilton B.E., Mathews T.J., and Chandra A. Trends and variations in smoking during pregnancy and low birth weight: evidence from the birth certificate, 1990-2000. Pediatrics 111 (2003) 1176-1180
41. Gold D.R., Burge H.A., Carey V., Milton D.K., Platts-Mills T., and Weiss S.T. Predictors of repeated wheeze in the first year of life: the relative roles of cockroach, birth weight, acute lower respiratory illness, and maternal smoking. Am J Respir Crit Care Med 160 (1999) 227-236
42. US Department of Health and Human Services. The health consequences of involuntary exposure to tobacco smoke: a report of the surgeon general-executive summary (2006), US Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA
43. Caraballo R.S., Giovino G.A., Pechacek T.F., and Mowery P.D. Factors associated with discrepancies between self reports on cigarette smoking and measured serum cotinine levels among persons aged 17 years or older. Am J Epidemiol 153 (2001) 807-814
44. Kendrick J.S., Zahniser C.S., Miller N., et al. Integrating smoking cessation into routine public prenatal care: the smoking cessation in pregnancy project. Am J Public Health 85 (1995) 217-222
45. Webb D.A., Boyd N.R., Messina D., and Windsor R.A. The discrepancy between self-reported smoking status and urine cotinine levels among women enrolled in prenatal care at four publicly funded clinical sites. J Public Health Manag Pract 9 (2003) 322-325
46. Mullen P.D., Carbonari J.P., Tabak E.R., and Glenday M.C. Improving disclosure of smoking by pregnant women. Am J Obstet Gynecol 165 (1991) 409-413
47. Melvin C.L., and Gaffney C.A. Treating nicotine use and dependence of pregnant and parenting smokers: an update. Nicotine Tob Res 6 (2004) S107-S124
48. Rosenthal A.C., Melvin C.L., and Barker D.C. Treatment of tobacco use in preconception care. Matern Child Health J 10 (2006) S147-S148
49. Fiore M.C., Bailey W.C., Cohen C.J., et al. A clinical practice guideline for treating tobacco use and dependence (2000), US Department of Health and Human Services, Public Health Service, Rockville, MD
50. Fiore M.C., Jaen C.R., Baker T.B., et al. Treating tobacco use and dependence: update. Clinical practice guideline (May 2008), US Department of Health and Human Services, Public Health Service, Rockville, MD
51. Substance Abuse and Mental Health Services Administration. Results from the 2001 national household survey on drug abuse. Summary of national findings. Vol 1 (2002), Substance Abuse and Mental Health Services Administration, Rockville, MD
52. ACOG Committee on Ethics. ACOG committee opinion. No. 294. At-risk drinking and illicit drug use: ethical issues in obstetric and gynecologic practice. Obstet Gynecol 103 (2004) 1021-1031
53. Handler A., Kistin N., Davis F., and Ferre C. Cocaine use during pregnancy: perinatal outcomes. Am J Epidemiol 135 (1992) 1425-1427
54. Hadeed A.J., and Siegel S.R. Maternal cocaine use during pregnancy: effect on the newborn infant. Pediatrics 84 (1989) 205-210
55. Addis A., Moretti M., Syed F., Einarson T., and Koren G. Fetal effects of cocaine: an updated meta-analysis. Reprod Toxicol 15 (2001) 341-369
56. Wolfe E.L., Davis T., Guydish J., and Delucchi K.L. Mortality risk associated with perinatal drug and alcohol use in California. J Perinatol 25 (2005) 93-100
57. Kelly R., Russo J., Holt V., et al. Psychiatric and substance use disorders as risk factors for low birth weight and preterm delivery. Obstet Gynecol 100 (2002) 297-304
58. Shiono P.H., Klebanoff M.A., Nugent R.P., et al. The impact of cocaine and marijuana use on low birth weight and preterm birth: a multicenter study. Am J Obstet Gynecol 172 (1995) 19-27
59. Day N.L., Richardson G.A., Goldschmidt L., et al. Effect of prenatal marijuana exposure on the cognitive development of offspring at age three. Neurotoxicol Teratol 16 (1994) 169-175
60. Goldschmidt L., Richardson G.A., Willford J., and Day N.L. Prenatal marijuana exposure and intelligence test performance at age 6. J Am Acad Child Adolesc Psychiatry (2008)
61. Frank D.A., Augustyn M., Knight W.G., Pell T., and Zuckerman B. Growth, development, and behavior in early childhood following prenatal cocaine exposure. JAMA 285 (2001) 1613-1625
62. Lanier D., and Ko S. Screening in primary care settings for illicit drug use: assessment of screening instruments-a supplemental evidence update for the US Preventive Services Task Force. Evidence synthesis No. 58, part 2. AHRQ publication No. 08-05108-EF-2 (2008), Agency for Healthcare Research and Quality, Rockville, MD January
63. US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Public Health Service, Center for Substance Abuse Treatment. TIP 24: a guide to substance abuse services for primary care clinicians. DHHS publication No. (SMA) 97-3139. Rockville, MD; 1997.
64. US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Public Health Service, Center for Substance Abuse Treatment. TIP 34: brief interventions and brief therapies for substance abuse. DHHS Publication No. (SMA) 99-3353. Rockville, MD; 1999.
65. US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Public Health Service, Center for Substance Abuse Treatment. TIP 35: enhancing motivation for change in substance abuse treatment. DHHS Publication No. (SMA) 99-3354. Rockville, MD; 1999.
66. Dutra L.D., Stathopoulou G., Basden S.L., Leyro T.M., Powers M.B., and Otto M.W. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry 165 (2008) 179-187
67. Kleber H.D. Pharmacologic treatments for heroin and cocaine dependence. Am J Addict 12 Suppl2 (2003) S5-S18
68. Connock M., Juaez-Garcia A., Jowett S., et al. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess 11 (2007) 1-171
69. Crits-Christoph P., Siqueland L., Blaine J., et al. Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse collaborative cocaine treatment study. Arch Gen Psychiatry 56 (1999) 493-502
70. Steinberg K.L., Roffman R.A., Carroll K.M., et al. Brief counseling for marijuana dependence: a manual for treating adults. DHHS publication No. (SMA) 05-4022 (2005), Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, Rockville, MD
71. Grant T.M., Ernst C.C., and Streissguth A.P. An intervention with high-risk mothers who abuse alcohol and drugs: the Seattle advocacy model. Am J Public Health 86 (1996) 1816-1817